AstraZeneca’s Pangalos: Cultural Diversity Is Key To Educating Scientists
Major Nears Equal Gender Ratios
Executive Summary
Mene Pangalos talked to Scrip about the importance of cultural diversity in a lab setting, pushing the frontiers on public-private partnerships and redoubling efforts on gene editing.
You may also be interested in...
AstraZeneca Focuses On COVID-19 Antibody Approach After Year Of Vaccine Headwinds
During its fourth quarter earnings call, the UK-based major expressed hopes that its prophylactic antibody approach would fare better after its COVID-19 jab faced several obstacles in developed markets last year.
AstraZeneca Clears Final Hurdle To Seal Alexion Takeover
Antitrust authorities in the UK have followed their counterparts in the EU, Japan and the US to approve the AstraZeneca and Alexion link-up, the biggest pharma M&A deal of 2020.
AdipoPharma Targets Root Cause Of Diabetes With First ‘Adipeutic’ Drug Candidate
Emerging Company Profile: The French biotech is developing a constrained peptide that targets an interaction in body fat tissue in the hopes of treating type 2 diabetes.